FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

806131000168102: Uptravi (selexipag 1.2 mg) tablet (trade product unit of use)


Status: current, Defined. Date: 30-Jun 2016. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3869021000168116 Uptravi (selexipag 1.2 mg) tablet (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
3869031000168118 Uptravi 1.2 mg tablet en Synonym Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Uptravi 1.2 mg tablet has manufactured dose form tablet true Inferred relationship Some
Uptravi 1.2 mg tablet Is a trade product unit of use true Inferred relationship Some
Uptravi 1.2 mg tablet Is a Uptravi true Inferred relationship Some
Uptravi 1.2 mg tablet Is a selexipag 1.2 mg tablet true Inferred relationship Some
Uptravi 1.2 mg tablet has manufactured dose form film-coated tablet false Inferred relationship Some
Uptravi 1.2 mg tablet has unit of use tablet true Inferred relationship Some 80314257
Uptravi 1.2 mg tablet has Australian BoSS selexipag true Inferred relationship Some 80314256
Uptravi 1.2 mg tablet has intended active ingredient selexipag true Inferred relationship Some 80314256

Inbound Relationships Type Active Source Characteristic Refinability Group
Uptravi 1.2 mg tablet, 60, blister pack has TPUU True Uptravi 1.2 mg tablet Inferred relationship Some 1
Uptravi 1.2 mg tablet, 60 has TPUU True Uptravi 1.2 mg tablet Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start